I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination (NCT04452526) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination
United States372 participantsStarted 2020-10-21
Plain-language summary
This trial studies how well a multi-level health system-based intervention works in improving human papillomavirus (HPV) vaccine initiation and completion among children in health systems in four Appalachian states. Utilizing educational and promotional materials and electronic health record reminders, may improve the uptake of the HPV vaccine in children and young adults, ultimately preventing the development of cervical cancer.
Who can participate
Age range
11 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
CLINIC
* Located in one of the counties that are part of this program
* Provides care to patients aged 11-26
* Provides immunizations
HEALTH CARE PROVIDERS (PHYSICIANS, NURSES) AND OFFICE STAFF
* Practicing in a clinic in one of the participating health systems
* Personnel involved in the vaccine process (determined by individual clinics)
* Able to speak, read, and write English
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in rate of human papillomavirus (HPV) vaccination initiation among 11-12 year olds
Timeframe: Baseline up to 24 months
2
Change in rate of HPV vaccination initiation among those 13-26
Timeframe: Baseline up to 24 months
3
Sustainability
Timeframe: Up to 24 months
4
Cost-effectiveness
Timeframe: Up to 60 months
5
Change in knowledge of providers
Timeframe: Baseline up to 60 months
6
Change in attitudes of providers
Timeframe: Baseline up to 60 months
Trial details
NCT IDNCT04452526
SponsorOhio State University Comprehensive Cancer Center